Evaluating long-term outcomes of treatments for uterine fibroids
Long Term Effectiveness of Uterine Sparing Fibroid Treatments
This study is looking at how well different treatments for fibroids work over time, especially for Black women who often face more challenges with this condition, to help improve their care and quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health System NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10916217 on NIH RePORTER |
What this research studies
This research investigates the long-term effectiveness of various uterine-sparing treatments for fibroids, particularly focusing on Black women who are disproportionately affected by this condition. By utilizing data from two multisite registries, the study aims to follow participants for up to 10 years to assess symptom improvement and the need for further interventions like hysterectomy. The research will consider important factors such as pre-treatment fibroid characteristics and quality of life, which have been overlooked in previous studies. This comprehensive approach seeks to fill critical knowledge gaps and improve treatment guidelines for women suffering from fibroids.
Who could benefit from this research
Good fit: Ideal candidates for this research include women, particularly Black women, who have undergone uterine-sparing treatments for fibroids and are willing to participate in long-term follow-up.
Not a fit: Patients who have already undergone a hysterectomy or do not have uterine fibroids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed treatment options and improved quality of life for women with uterine fibroids.
How similar studies have performed: Previous research has shown success in evaluating short-term outcomes of fibroid treatments, but this study aims to provide novel insights through long-term follow-up.
Where this research is happening
Detroit, United States
- Henry Ford Health System — Detroit, United States (Active)
Researchers
- Principal investigator: Wegienka, Ganesa Rebecca — Henry Ford Health System
- Study coordinator: Wegienka, Ganesa Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.